These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
77-0390628
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
5615 Scotts Valley Drive, Suite 110
Scotts Valley, California
|
95066
|
|
|
(Address of principal executive offices)
|
(Zip Code))
|
|
Large accelerated filer
o
|
(Do not check if a smaller reporting company)
|
||||
| Page | |
|
PART I — FINANCIAL INFORMATION
|
1
|
|
Item 1 —
Financial Statements.
|
1
|
|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
|
|
13
|
|
|
18
|
|
|
Item 4 —
Controls and Procedures
|
18
|
|
PART II — OTHER INFORMATION
|
20
|
|
Item 1 —
Legal Proceedings
|
20
|
|
Item 1A —
Risk Factors
|
20
|
|
Item 6 —
Exhibits
|
39
|
|
40
|
|
|
41
|
|
June 30,
2011
|
December 31,
2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 53,051 | $ | 34,635 | ||||
|
Investments
|
12,848 | 43,457 | ||||||
|
Accounts receivable, net
|
— | 3 | ||||||
|
Prepaid taxes
|
7,488 | — | ||||||
|
Current deferred tax benefit
|
— | 1,735 | ||||||
|
Prepaid expense and other current assets
|
260 | 87 | ||||||
|
Total current assets
|
73,647 | 79,916 | ||||||
|
Property and equipment, net
|
19 | 25 | ||||||
|
Intangible and other assets
|
84 | 108 | ||||||
|
Long-term deferred tax benefit, net
|
54 | 1,645 | ||||||
|
Total assets
|
$ | 73,804 | $ | 81,694 | ||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued liabilities
|
$ | 870 | $ | 519 | ||||
|
Income tax liability
|
— | 7,358 | ||||||
|
Derivative liability
|
16,880 | 14,364 | ||||||
|
Total current liabilities
|
17,750 | 22,241 | ||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares, issued and outstanding: 0 shares at June 30,2011 and December 31, 2010, respectively
|
— | — | ||||||
|
Common stock, par value $0.0001 per share Authorized: 100,000,000 shares, issued and outstanding: 49,899,892 shares at June 30, 2011 and 49,341,028 at December 31, 2010
|
5 | 5 | ||||||
|
Additional paid in capital
|
91,740 | 78,187 | ||||||
|
Accumulated deficit
|
(35,667 | ) | (17,755 | ) | ||||
|
Accumulated other comprehensive loss
|
(24 | ) | (984 | ) | ||||
|
Total stockholders’ equity
|
56,054 | 59,453 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 73,804 | $ | 81,694 | ||||
|
Three Months
Ended
June 30, 2011
|
Three Months
Ended
June 30, 2010
(As Restated)
|
|||||||
|
Revenue — royalties
|
$ | 1 | $ | 23 | ||||
|
Operating expense:
|
||||||||
|
Royalty expense
|
— | 59,239 | ||||||
|
Research and development
|
235 | 1,228 | ||||||
|
General, selling and administrative
|
3,520 | 24,455 | ||||||
|
Gain on settlement
|
— | (200,000 | ) | |||||
|
Total operating expense (income)
|
3,755 | (115,078 | ) | |||||
|
Income (loss) from operations
|
(3,754 | ) | 115,101 | |||||
|
Loss on change in value of embedded derivative and warrants
|
(7,059 | ) | (2,537 | ) | ||||
|
Interest and other income, net
|
68 | 12 | ||||||
|
Income (loss) before taxes
|
(10,745 | ) | 112,576 | |||||
|
Income tax expense (benefit)
|
(940 | ) | 34,000 | |||||
|
Net Income (loss)
|
$ | (9,805 | ) | $ | 78,576 | |||
|
Basic earnings (loss) per share:
|
$ | (0.20 | ) | $ | 1.78 | |||
|
Diluted earnings (loss) per share:
|
$ | (0.20 | ) | $ | 1.67 | |||
|
Weighted average shares outstanding basic
|
49,748 | 44,277 | ||||||
|
Weighted average shares outstanding diluted
|
49,748 | 47,266 | ||||||
|
Six Months
Ended
June 30, 2011
|
Six Months
Ended
June 30, 2010
(As Restated)
|
|||||||
|
Revenue — royalties
|
$ | 17 | $ | 44 | ||||
|
Operating expense:
|
||||||||
|
Royalty expense
|
— | 59,239 | ||||||
|
Research and development
|
431 | 1,750 | ||||||
|
General, selling and administrative
|
6,093 | 28,411 | ||||||
|
Gain on settlement
|
—
|
(200,000 | ) | |||||
|
Total operating expense (income)
|
6,524 | (110,600 | ) | |||||
|
Income (loss) from operations
|
(6,507 | ) | 110,644 | |||||
|
Loss on change in value of embedded derivative and warrants
|
(12,189 | ) | (6,982 | ) | ||||
|
Interest and other income, net
|
128 | 13 | ||||||
|
Income (loss) before taxes
|
(18,568 | ) | 103,675 | |||||
|
Income tax expense (benefit)
|
(1,640 | ) | 34,000 | |||||
|
Net Income (loss)
|
$ | (16,928 | ) | $ | 69,675 | |||
|
Basic earnings (loss) per share:
|
$ | (0.34 | ) | $ | 1.63 | |||
|
Diluted earnings (loss) per share:
|
$ | (0.34 | ) | $ | 1.54 | |||
|
Weighted average shares outstanding basic
|
49,605 | 42,721 | ||||||
|
Weighted average shares outstanding diluted
|
49,605 | 45,248 | ||||||
|
Six Months
Ended
June 30, 2011
|
Six Months
Ended
June 30, 2010
(As Restated)
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$ | (16,928 | ) | $ | 69,675 | |||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Stock-based compensation
|
1,856 | 1,566 | ||||||
|
Depreciation and amortization
|
30 | 30 | ||||||
|
Net change in deferred taxes
|
3,606 | — | ||||||
|
Change in value of derivative liability
|
12,189 | 6,982 | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Receivables and other current assets
|
(170 | ) | (19 | ) | ||||
|
Pre paid taxes
|
(7,488 | ) | — | |||||
|
Accounts payable and accrued liabilities
|
351 | 30,094 | ||||||
|
Income tax liability
|
(7,358 | ) | --- | |||||
|
Net cash provided by (used in) operating activities
|
(13,912 | ) | 108,328 | |||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property and equipment
|
— | (2 | ) | |||||
|
Proceeds from sale of investments, net
|
30,585 | — | ||||||
|
Net cash provided by (used in) investing activities
|
30,585 | (2 | ) | |||||
|
Cash flows from financing activities:
|
||||||||
|
Payment of royalty obligation less imputed interest
|
— | (160 | ) | |||||
|
Proceeds from exercise of options
|
175 | 272 | ||||||
|
Proceeds from exercise of warrants
|
1,568 | 16,730 | ||||||
|
Net cash provided by financing activities
|
1,743 | 16,842 | ||||||
|
Net increase in cash and cash equivalents
|
18,416 | 125,168 | ||||||
|
Cash and cash equivalents, beginning of period
|
34,635 | 2,011 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 53,051 | $ | 127,179 | ||||
|
Supplemental disclosure of cash flow information:
|
||||||||
|
Cash paid during the period for taxes
|
$ | — | $ | — | ||||
|
Cash paid during the period for interest
|
$ | — | $ | 10 | ||||
|
Supplemental disclosure of noncash investing and financing activities:
|
||||||||
|
In April 2011 a cashless exercise of 30,000 underwriter warrants at $4.80 resulted in the issuance of 24,178 common shares.
|
||||||||
|
|
·
persuasive evidence of sales arrangements;
|
|
|
·
delivery has occurred or services have been rendered;
|
|
|
·
the buyer’s price is fixed or determinable; and
|
|
|
·
collection is reasonably assured.
|
|
|
Assets at Fair Value as of June 30, 2011
|
||||||||||||||||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Certificates of deposit
|
$ | 2,745,339 | — | — | $ | 2,745,339 | |||||||||||
|
Corporate Bonds:
|
|||||||||||||||||
|
AA
|
2,051,230 | — | — | 2,051,230 | |||||||||||||
| A | 8,051,521 | — | — | 8,051,521 | |||||||||||||
|
Total Corporate Bonds
|
10,102,751 | — | — | 10,102,751 | |||||||||||||
|
Total Investments at Fair Value
|
$ | 12,848,090 | — | — | $ | 12,848,090 | |||||||||||
|
|
Fair Value Measurements at June 30, 2011
|
|
|||||||||||
|
|
Quoted
Prices in
Active
Markets for
Identical
Assets
|
|
Significant
Other
Observable
Inputs
|
|
Significant
Unobservable
Inputs
|
|
|
|
|||||
|
|
(Level 1)
|
|
(Level 2)
|
|
(Level 3)
|
|
|
Total
|
|
||||
|
Series l Warrants
|
$ | — |
$
|
—
|
|
$
|
16,879,957
|
|
|
$
|
16,879,957
|
|
|
|
Total
|
$ | — |
$
|
—
|
|
$
|
16,879,957
|
|
|
$
|
16,879,957
|
|
|
|
|
|
Fair Values
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
|
|
|
|
Balance December 31, 2010
|
|
$
|
14,364,350
|
|
|
Net loss included in earnings
|
|
|
12,189,379
|
|
|
Settlements
|
|
|
(9,673,772
|
)
|
|
Balance June 30, 2011
|
|
$
|
16,879,957
|
|
|
The amount of total losses for the period attributable to the change in unrealized losses relating to assets still held at the reporting date.
|
$
|
(2,515,606)
|
||
|
June 30, 2011
|
June 30, 2010
|
|||||||
|
Current
|
$ | (4,965,000 | ) | $ | 34,000,000 | |||
|
Deferred
|
3,325,000 | — | ||||||
|
Total
|
$ | (1,640,000 | ) | $ | 34,000,000 | |||
|
June 30, 2011
|
June 30, 2010
|
|||||||
|
Tax provision (benefit at statutory rate)
|
$ | (6,500,000 | ) | $ | 37,500,000 | |||
|
Non-deductible change in derivative liability
|
4,300,000 | 500,000 | ||||||
|
Change in deferred tax allowance
|
200,000 | (10,000,000 | ) | |||||
|
ISO stock options
|
160,000 | — | ||||||
|
R&D tax credit
|
220,000 | — | ||||||
|
Other
|
(20,000 | ) | 6,000,000 | |||||
|
Total
|
$ | (1,640,000 | ) | $ | 34,000,000 | |||
|
June 30, 2011
|
June 30, 2010
|
|||||||
|
Deferred tax benefit of net operating loss carryforwards
|
$ | 1,900,000 | $ | 1,000,000 | ||||
|
California franchise tax deduction
|
(3,300,000 | ) | — | |||||
|
Other
|
275,000 | — | ||||||
|
Subtotal
|
(1,125,000 | ) | 1,000,000 | |||||
|
Less utilization allowance
|
(2,200,000 | ) | (1,000,000 | ) | ||||
|
Total
|
$ | (3,325,000 | ) | $ | — | |||
|
Minimum
Required Lease
Payments
in Period
|
||||
|
For remainder of Fiscal Year 2011
|
$ | 30,202 | ||
|
Fiscal Year ending December 31, 2012
|
30,202 | |||
| $ | 60,404 | |||
|
Original
Number of
Warrants
Issued
|
Exercise
Price per
Common
Share
|
Exercisable at
December 31,
2010
|
Became
Exercisable
|
Exercised
|
Terminated /
Cancelled /
Expired
|
Exercisable
at June 30,
2011
|
Termination
|
||||||||||||||||||||
| 300,000 | $ | 4.80 | (1) | 30,000 | — | (30,000 | ) | — | — |
December 2012
|
|||||||||||||||||
| 2,619,036 | $ | 3.59 | 1,060,444 | — | (437,526 | ) | — | 622,918 |
March 2015
|
||||||||||||||||||
|
Total
|
1,090,444 | (467,526 | ) | — | 622,918 | ||||||||||||||||||||||
|
(1)
|
Represents the cashless exercise in April 2011, of 2007 underwriter warrants, resulting in 24,178 common shares issued.
|
|
·
|
credit risk and higher levels of payment fraud;
|
|
·
|
potentially adverse tax consequences; and
|
|
·
|
other higher costs associated with doing business internationally.
|
|
·
|
we may not be successful in entering into licensing relationships with our targeted customers on commercially acceptable terms; and
|
|
·
|
challenges to the validity of certain of our patents underlying our licensing opportunities.
|
|
|
·
|
substantially greater financial, technical and marketing resources;
|
|
|
·
|
a larger customer base;
|
|
|
·
|
better name recognition; and
|
|
|
·
|
more expansive product offerings.
|
|
|
·
|
our applications for patents, trademarks and copyrights relating to our business may not be granted and, if granted, may be challenged or invalidated;
|
|
|
·
|
issued trademarks, copyrights, or patents may not provide us with any competitive advantages;
|
|
|
·
|
our efforts to protect our intellectual property rights may not be effective in preventing misappropriation of our technology; or
|
|
|
·
|
our efforts may not prevent the development and design by others of products or technologies similar to or competitive with, or superior to those we develop.
|
|
|
·
|
New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue.
|
|
|
·
|
Trial judges and juries sometimes find it difficult to understand complex patent enforcement litigation, and as a result, we may need to appeal adverse decisions by lower courts in order to successfully enforce our patents.
|
|
|
·
|
More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.
|
|
|
·
|
Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.
|
|
|
·
|
As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.
|
|
|
·
|
unwillingness of consumers to shift to VoIP and use other such next-generation Internet-based applications;
|
|
|
·
|
refusal to purchase security products to secure information transmitted through such applications;
|
|
|
·
|
perception by the licensees of unsecure communication and data transfer;
|
|
|
·
|
lack of concern for privacy by licensees and users;
|
|
|
·
|
limitations on access and ease of use;
|
|
|
·
|
congestion leading to delayed or extended response times;
|
|
|
·
|
inadequate development of Internet infrastructure to keep pace with increased levels of use; and
|
|
|
·
|
increased government regulations.
|
|
|
·
|
the need to educate potential customers about our patent rights and our product and service capabilities;
|
|
|
·
|
customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;
|
|
|
·
|
customers’ budgetary constraints;
|
|
|
·
|
the timing of customers’ budget cycles; and
|
|
|
·
|
delays caused by customers’ internal review processes.
|
|
|
·
|
design, develop, launch and/or license our planned products, services and technologies that address the increasingly sophisticated and varied needs of our prospective customers; and
|
|
|
·
|
respond to technological advances and emerging industry standards and practices on a cost-effective and timely basis.
|
|
|
·
|
the price of our products relative to other products that seek to secure real-time communication;
|
|
|
·
|
the perception by users of the effectiveness of our products;
|
|
|
·
|
our ability to fund our sales and marketing efforts; and
|
|
|
·
|
the effectiveness of our sales and marketing efforts.
|
|
|
·
|
power loss, transmission cable cuts and other telecommunications failures;
|
|
|
·
|
damage or interruption caused by fire, earthquake, and other natural disasters;
|
|
|
·
|
computer viruses or software defects; and
|
|
|
·
|
physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.
|
|
|
·
|
the need for continued development of the financial and information management systems;
|
|
|
·
|
the need to manage relationships with future licensees, resellers, distributors and strategic partners;
|
|
|
·
|
the need to hire and retain skilled management, technical and other personnel necessary to support and manage our business; and
|
|
|
·
|
the need to train and manage our employee base.
|
|
|
·
|
challenges caused by distance, language and cultural differences;
|
|
|
·
|
legal, legislative and regulatory restrictions;
|
|
|
·
|
currency exchange rate fluctuations;
|
|
|
·
|
economic instability; and
|
|
|
·
|
longer payment cycles in some countries.
|
|
|
·
|
developments in any then-outstanding litigation;
|
|
|
·
|
quarterly variations in our operating results;
|
|
|
·
|
large purchases or sales of common stock;
|
|
|
·
|
actual or anticipated announcements of new products or services by us or competitors;
|
|
|
·
|
general conditions in the markets in which we compete; and
|
|
|
·
|
economic and financial conditions.
|
|
·
|
the outcome of enforcement actions currently in progress or that we may undertake in the future, and the timing thereof;
|
|
·
|
the amount and timing of receipt of license fees from potential infringers, licensees or customers;
|
|
·
|
the outcome of actions we have taken and may take in the future to enforce our intellectual property rights;
|
|
·
|
the rate of adoption of our patented technologies;
|
|
·
|
the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc;
|
|
·
|
the success of a licensee in selling products that use our patented technologies; and
|
|
·
|
the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights.
|
|
|
·
|
A staggered Board of Directors
: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting. This has the effect of delaying the ability of stockholders to effect a change in control of us since it would take two annual meetings to effectively replace at least three directors which represents a majority of the Board of Directors.
|
|
|
·
|
Blank check preferred stock:
Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to existing stockholders. In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors. We have not adopted such a “poison pill;” but our Board of Directors has the
ability to do so in the future, very rapidly and without stockholder approval.
|
|
|
·
|
Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings:
Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.
|
|
|
·
|
No stockholder actions by written consent:
No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.
|
|
|
·
|
Super majority requirement for stockholder amendments to the By-laws:
Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares.
|
|
|
·
|
Elimination of the ability of stockholders to call a special meeting of the stockholders:
Only the Board of Directors or management can call special meetings of the stockholders. This could mean that stockholders, even those who represent a significant block of our shares, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.
|
|
Exhibit
Number
|
Description
|
|
|
10.20
|
VirnetX Holding Corporation Fiscal 2011 Director Compensation Program.
|
|
|
10.21
|
Description of Named Executive Officer Salary Increases (incorporated by reference to Item 5.02 of the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on April 13, 2011)
|
|
|
31.1
|
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1*
|
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2*
|
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101**
|
Interactive Data Files
|
|
*
|
This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we
explicitly incorporate them by reference.
|
|
**
|
These exhibits will be furnished in an amendment to this Quarterly Report on Form 10-Q as permitted by Rule 405 of Regulation S-T.
|
|
VIRNETX HOLDING CORPORATION
|
||
|
|
By:
|
/s/ Kendall Larsen |
|
Name Kendall Larsen
|
||
|
Title
Chief Executive Officer (Principal
|
||
| Executive Officer) | ||
| By: | /s/ William E. Sliney | |
| Name William E. Sliney | ||
| Title Chief Financial Officer (Principal | ||
| Financial Officer and Principal | ||
| Accounting Officer) | ||
| Date: August 09, 2011 | ||
|
Exhibit
Number
|
Description
|
|
|
VirnetX Holding Corporation Fiscal 2011 Director Compensation Program.
|
||
|
10.21
|
Description of Named Executive Officer Salary Increases (incorporated by reference to Item 5.02 of the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on April 13, 2011)
|
|
|
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
101**
|
Interactive Data Files
|
|
*
|
This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
|
|
**
|
These exhibits will be furnished in an amendment to this Quarterly Report on Form 10-Q as permitted by Rule 405 of Regulation S-T.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|